Issue

Vol. 33 No. 9 (2021): Vol 33 Issue 9, 2021

Copyright (c) 2021 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Vegetable Oil-Based Self-Microemulsifying Drug Delivery System of Eprosartan Mesylate: in vitro and ex vivo Evaluation

https://doi.org/10.14233/ajchem.2021.23288
Sabitri Bindhani
Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O'Anusandhan University, Bhubaneswar-751030, India
Snehamayee Mohapatra
Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O'Anusandhan University, Bhubaneswar-751030, India
Rajat Kumar Kar
Department of Pharmaceutics, Dadhichi College of Pharmacy, Vidya Vihar, Sundargram-754002, India

Corresponding Author(s) : Sabitri Bindhani

sabitridas49@gmail.com

Asian Journal of Chemistry, Vol. 33 No. 9 (2021): Vol 33 Issue 9, 2021

Abstract

This study was planned to increase the intestinal permeability and thereby bioavailability of eprosartan mesylate (EPM) by designing a self-microemulsifying drug delivery system (SMEDDS) by the use of vegetable oils. Various SMEDDS-based formulations were prepared with oleic acid and peppermint oil. Tween 80 was used as surfactant and PEG 400 as co-surfactant. Pseudo ternary phase diagrams were constructed for identifying emulsification region between 1:1, 1:2, 2:1, 3:1 ratio of SCOS mix. Eight batches of SMEDDS were found to be thermodynamically stable and from which SMEDDSOF9 and PF5 were best formulations due to their highest drug content, minimum particle size. They have shown highest release of drug in vitro and higher in vitro drug diffusion and ex vivo permeation analysis than pure drug. FTIR study ascertained no incompatibility between drug and excipients present in formulation. From the accelerated stability study, slight effect on particle size and zeta potential, assay content along with cumulative % of drug release was found. The results demonstrated the SMEDDS of EPM are potent drug delivery system to increase dissolution rate and bioavailability of drug via increased intestinal permeability and consequently improving the therapeutic efficacy of eprosartan mesylate.

Keywords

Self-microemulsification Vegetable oils Eprosartan mesylate Bioavailability ex vivo Intestinal permeability
Bindhani, S., Mohapatra, S., & Kumar Kar, R. (2021). Vegetable Oil-Based Self-Microemulsifying Drug Delivery System of Eprosartan Mesylate: in vitro and ex vivo Evaluation. Asian Journal of Chemistry, 33(9), 2182–2190. https://doi.org/10.14233/ajchem.2021.23288
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. A.G. Agrawal, A. Kumar and P.S. Gide, Colloids Surf. B Biointerfaces, 126, 553 (2015); https://doi.org/10.1016/j.colsurfb.2014.11.022
  2. K.T. Savjani, A.K. Gajjar and J.K. Savjani, Int. Scholarly Res. Notices, 2012, 195727 (2012); https://doi.org/10.5402/2012/195727
  3. S. Kalepu and V. Nekkanti, Acta Pharm. Sin. B, 5, 442 (2015); https://doi.org/10.1016/j.apsb.2015.07.003
  4. A. Pensado, B. Seijo and A. Sanchez, Expert Opin. Drug Deliv., 11, 1721 (2014); https://doi.org/10.1517/17425247.2014.935337
  5. A.H. Najafabadi, M. Abdouss and S. Faghihi, Mater. Sci. Eng. C Mater Biol Appl., 41, 91 (2014); https://doi.org/10.1016/j.msec.2014.04.035
  6. P.V. Patel, H.K. Patel, T.A. Mehta and S.S. Panchal, Int. J. Pharm. Investig., 3, 95 (2013); https://doi.org/10.4103/2230-973X.114899
  7. P. Hyma and K. Abbulu, Biomed. Prevent Nutr., 3, 345 (2013); https://doi.org/10.1016/j.bionut.2013.09.005
  8. R.N. Gursoy and S. Benita, Biomed. Pharmacother., 58, 173 (2004); https://doi.org/10.1016/j.biopha.2004.02.001
  9. P. Dangre, R. Gilhotra and S. Dhole, Drug Deliv. Transl. Res., 6, 610 (2016); https://doi.org/10.1007/s13346-016-0318-7
  10. H.W. Xin, C. Wu, Q. Li, A.R. Yu, M. Zhu, Y. Shen, D. Su and L. Xiong, Br. J. Clin. Pharmacol., 64, 469 (2007); https://doi.org/10.1111/j.1365-2125.2007.02922.x
  11. X.L. Qin, H.C. Bi, X.D. Wang, J.L. Li, Y. Wang, X.P. Xue, X. Chen, C.X. Wang, L.J. Xu, Y.T. Wang and M. Huang, Int. J. Pharm., 389, 114 (2010); https://doi.org/10.1016/j.ijpharm.2010.01.025
  12. B.D. Rege, J.P. Kao and J.E. Polli, Eur. J. Pharm. Sci., 16, 237 (2002); https://doi.org/10.1016/S0928-0987(02)00055-6
  13. G.L. Plosker, Drugs, 69, 2477 (2009); https://doi.org/10.2165/11203980-000000000-00000
  14. L. Ruilope and B. Jager, Expert Opin. Pharmacother., 4, 107 (2003); https://doi.org/10.1517/14656566.4.1.107
  15. S. Borker and A. Pawar, Adv. Sci. Eng. Med., 5, 1297 (2013); https://doi.org/10.1166/asem.2013.1417
  16. C. Atmakuri, Z. Attari, G. Pai and K.B. Koteswara, J. Int. Res. Pharm. Sci., 7, 34 (2016).
  17. P. Dangre, M.D. Godbole, P.V. Ingale and D.K. Mahapatra, J. Indian Pharm. Educ. Res., 50(3s), S209 (2016); https://doi.org/10.5530/ijper.50.3.31
  18. D.H. Oh, J.H. Kang, D.W. Kim, B.J. Lee, J.O. Kim, C.S. Yong and H.- G. Choi, Int. J. Pharm., 420, 412 (2011); https://doi.org/10.1016/j.ijpharm.2011.09.007
  19. S. Nazzal, I.I. Smalyukh, O.D. Lavrentovich and M.A. Khan, Int. J. Pharm., 235, 247 (2002); https://doi.org/10.1016/S0378-5173(02)00003-0
  20. E. Patel and K.K. Sawant, Drug Dev. Ind. Pharm., 33, 1318 (2007); https://doi.org/10.1080/03639040701385527
  21. X. Wu, J. Xu, X. Huang and C. Wen, Drug Dev. Ind. Pharm., 37, 15 (2011); https://doi.org/10.3109/03639045.2010.489560
  22. M.O. Bachynsky, N.H. Shah, C.I. Patel and A.W. Malick, Drug Dev. Ind. Pharm., 23, 809 (1997); https://doi.org/10.3109/03639049709150551
  23. X. Qi, L. Wang, J. Zhu, Z. Hu and J. Zhang, Int. J. Pharm., 409, 245 (2011); https://doi.org/10.1016/j.ijpharm.2011.02.047
  24. P. Zhang, Y. Liu, N. Feng and J. Xu, Int. J. Pharm., 355, 269 (2008); https://doi.org/10.1016/j.ijpharm.2007.12.026
  25. V.D. Vemuri and S. Lankalapalli, J. Indian Pharm. Educ. Res., 53, s539 (2019); https://doi.org/10.5530/ijper.53.4s.148
  26. S. Gupta, S. Chavhan and K.K. Sawant, Colloids Surf. A: Physicochem. Eng Aspects, 392, 145 (2011); https://doi.org/10.1016/j.colsurfa.2011.09.048
  27. S. Beg, S. Swain, H.P. Singh, N. Patra and M.E. Rao, AAPS Pharm. Sci. Technol., 13, 1416 (2012); https://doi.org/10.1208/s12249-012-9865-5
  28. K. Balakumar, C.V. Raghavan, N.T. selvan, R.H. prasad and S. Abdu, Colloids Surf. B Biointerfaces, 112, 337 (2013); https://doi.org/10.1016/j.colsurfb.2013.08.025
  29. S.T. Prajapati, H.A. Joshi and C.N. Patel, J. Pharm., 2013, 728425 (2013); https://doi.org/10.1155/2013/728425
  30. A.K. Singh, A. Chaurasiya, M. Singh, S.C. Upadhyay, R. Mukherjee and R.K. Khar, AAPS PharmSciTech, 9, 628 (2008); https://doi.org/10.1208/s12249-008-9080-6
  31. V.R. Kallakunta, S. Bandari, R. Jukanti and P.R. Veerareddy, Powder Technol., 221, 375 (2012); https://doi.org/10.1016/j.powtec.2012.01.032
  32. L.M. Negi, M. Tariq and S. Talegaonkar, Colloids Surf. B Biointerfaces, 111, 346 (2013); https://doi.org/10.1016/j.colsurfb.2013.06.001
  33. A. Chudasama, B. Shah, V. Patel, M. Nivsarkar, K. Vasu and C. Shishoo, J. Pharm. Investig., 45, 271 (2015); https://doi.org/10.1007/s40005-015-0172-5
  34. N. Pongcharoenkiat, G. Narsimhan, R.T. Lyons and S.L. Hem, J. Pharm. Sci., 91, 559 (2002); https://doi.org/10.1002/jps.10064
  35. Y.S. Elnaggar, M.A. El-Massik and O.Y. Abdallah, Int. J. Pharm., 380, 133 (2009); https://doi.org/10.1016/j.ijpharm.2009.07.015
  36. P.P. Constantinides, J.P. Scalart, C. Lancaster, J. Marcello, G. Marks, H. Ellens and P.L. Smith, Pharm. Res., 11, 1385 (1994); https://doi.org/10.1023/A:1018927402875
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 1